IP Library Granted Patent US 11,969,200
Granted Patent B2
US 11,969,200 · App. 17/094,629 · Granted Apr 30, 2024

Eustachian tube modification

Inventors: Jerome Hester (Menlo Park, CA); Andrew Frazier (Sunnyvale, CA); Gregory Ng (San Leandro, CA); Scott J. Wolf (Menlo Park, CA)
Assignee: Aerin Medical Inc.
A61B18/1206A61B18/1485A61B18/20A61B2017/00092A61B17/24A61B2018/00005A61B2018/00083A61B2018/0022A61B2018/00327A61B2018/00565A61B2018/00577A61B2018/00595A61B2018/00642A61B2018/00821A61B2018/00875A61B18/0218A61B2018/046A61B2018/1253A61B2018/126A61B2018/143A61B2018/1467A61F11/202
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,969,200
App. No.
17/094,629
Granted
Apr 30, 2024
Kind
B2
Abstract

Disclosed embodiments relate to devices, systems, and methods of shaping, shrinking, opening, dilating, stiffening, or otherwise modifying a Eustachian tube and its surrounding tissue in order to improve the Eustachian tube's function. For example, patients with blocked, closed, or hypertrophic Eustachian tubes may be able to achieve improved function including easier equalization of pressure between the inner ear and environment.

Claims (21)

1. A method of treating a Eustachian tube, the method comprising:

advancing a treatment element of a Eustachian tube treatment device through a nostril;

inserting a passive positioner extending from the treatment element of the Eustachian tube treatment device through an ostium of the Eustachian tube;

contacting a treatment surface of the treatment element of the Eustachian tube treatment device with surface tissue surrounding a portion of the ostium of the Eustachian tube, wherein the treatment surface comprises:

a flat, arcuate shape;

a first arcuate row of radiofrequency electrodes protruding from the treatment surface; and

a second arcuate row of radiofrequency electrodes protruding from the treatment surface;

applying force with the treatment surface against the tissue to temporarily deform the tissue;

applying radiofrequency energy from the first arcuate row of radiofrequency electrodes on the treatment surface through the tissue and an underlying tissue beneath the tissue to the second arcuate row of radiofrequency electrodes on the treatment surface, to alter at least one property of the underlying tissue;

sensing a temperature of the surface tissue with a thermocouple on the treatment surface; and

adjusting an amount of the radiofrequency energy applied from the first arcuate row of radiofrequency electrodes to the second arcuate row of radiofrequency electrodes, based at least in part on the sensed temperature.

2. The method of claim 1 , wherein the underlying tissue is selected from the group consisting of muscle, cartilage, ligament, tendon, and nerve.

3. The method of claim 1 , further comprising:

bending a shaft of the Eustachian tube treatment device before advancing the Eustachian tube treatment device through the nostril, wherein a distal end of the shaft is coupled with the treatment element.

4. The method of claim 1 , wherein the tissue comprises mucosa surrounding the Eustachian tube.

5. The method of claim 1 , wherein applying the radiofrequency energy treats the Eustachian tube by affecting an amount of contraction of one or more muscles of the Eustachian tube.

6. The method of claim 1 , wherein the underlying tissue is selected from the group consisting of cartilage of the Eustachian tube, bone of the Eustachian tube, a torus of the Eustachian tube, a tensor tympani muscle of the Eustachian tube, and muscles that affect functioning of the Eustachian tube.

7. The method of claim 1 , wherein applying the radiofrequency energy through the tissue comprises shaping, shrinking, opening, dilating, or stiffening the Eustachian tube ostium.

8. The method of claim 1 , further comprising cooling the tissue before, during, or after applying the radiofrequency energy.

9. The method of claim 1 , wherein applying the radiofrequency energy comprises delivering the radiofrequency energy for between 15 seconds and 1 minute.

10. The method of claim 9 , wherein delivering the radiofrequency energy comprises heating the surface tissue to a temperature of about 50 degrees Celsius to about 70 degrees Celsius.

Assignments (2)
SECURITY INTEREST Recorded Dec 20, 2024
From: AERIN MEDICAL INC.
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 069746/0508 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2020
From: HESTER, JEROME; FRAZIER, ANDREW; NG, GREGORY; WOLF, SCOTT J.
To: AERIN MEDICAL, INC.
Reel/Frame 054348/0136 →
Continuity (3)
Continuation 15449322 · Mar 3, 2017
Provisional Application 62303711 · Mar 4, 2016
Related Publication 20210052318A1 · Feb 25, 2021
Cited By (4)
US 12,336,750 US 12,357,817 US 12,471,978 US 12,636,073